Geisinger Clinic
Danville, Pennsylvania, 17822, United States
NCT Number: NCT05012163
In the current study, the study team will explore whether small incentives are effective at promoting flu vaccine uptake. The study is designed to compare the relative efficacy of incentives of equal perceived expected value (EV) or equal implementation costs, to assess whether people are more likely to get vaccinated in response to lotteries with very high payoffs than to small certain cash payout or slightly higher-probability, more moderate payoffs. In particular, given the potential appeal of official state lottery tickets, one study arm will receive a Pennsylvania scratch-off lottery ticket for getting a flu vaccine. A primary hypothesis is that lotteries will outperform simple reminders (encouraging respondents to get the flu shot at their upcoming appointment) and the standard of care, representing the ambient healthcare system and public health campaigns to increase vaccination.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Danville, Pennsylvania, 17822, United States
During the 2021-22 flu season, the study team will contact Geisinger patients who have a primary care or specialist appointment scheduled during flu season and encourage them to get a flu shot.
Patients will be randomized into 4 to 9 study arms, depending on a sample size projection completed in August 2021. Arms will test the relative efficacy of a variety of small monetary incentives on flu shot uptake. Incentives may include (a) a $1 Pennsylvania scratch-off lottery ticket (with top prize of $5,000), (b) $1 in cash, (c) entry into a raffle for $5,000 absent upfront odds, (d) entry into a raffle for $5,000, with 1-in-5,000 odds of winning, (d) entry into a raffle for $50, with 1-in-50 odds of winning, and (e) entry into a raffle for $500, with 1-in-500 odds of winning. There will be one no-contact control arm and at least 1 reminder control arm (with additional control arms added given sufficient sample size and additional message versions to be tested).
Included in the study will be current Geisinger patients 18+ years of age with no contraindications for flu vaccine who have an appointment scheduled during the study period with a provider who can administer the vaccine. The primary study outcomes will be the rates of flu vaccination and flu diagnosis during the 2021-22 season by targeted patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Letter, short message service (SMS) text, phone, and/or email
Letter, SMS, phone, and/or email
Letter, SMS, phone, and/or email
Time frame: 3 days after patient is randomized
Received flu vaccination at relevant PCP or specialty appointment.
Time frame: Within 7 days of when patient is randomized
Received flu vaccination
Time frame: During the 2021-22 flu season (Up to 8 months, from the time the patient is randomized through April 30, 2022)
Received a "high confidence flu" diagnosis (with positive polymerase chain reaction [PCR]/antigen/molecular test) and/or "likely flu" diagnosis (as assessed via International Classification of Disease [ICD] codes or Tamiflu administration or positive PCR/antigen/molecular test)
Note that "likely flu" is a superset of the "high confidence flu" diagnoses.
Time frame: During the 2021-22 flu season (Up to 11 months, from the time the patient is randomized through July 31, 2022)
Diagnosed with flu-related complications
Time frame: Within 28 days of when the study subject is randomized
Cohabitant of study subject received flu vaccination
Time frame: 3 days after the patient is randomized.
Received flu vaccination at relevant PCP or specialty appointment.
Time frame: 3 days after the patient is randomized.
Received flu vaccination at relevant PCP or specialty appointment.
Time frame: 3 days after the patient is randomized.
Received flu vaccination at relevant PCP or specialty appointment.
National Bureau of Economic Research, Inc.
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05009251
Behavior, Health Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT04323137
Behavior, Health Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT05509283
Behavior, Health Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT06124131
Behavior, COVID-19
New Orleans, Louisiana, United States
View Trial Details